HEXAGON CAPITAL PARTNERS LLC – Bristol-Myers Squibb Company Transaction History
HEXAGON CAPITAL PARTNERS LLC portfolio value:
$688,000
portfolio value
HEXAGON CAPITAL PARTNERS LLC quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +25.64% | 1.97K shares | 95K | $71.09 | 9.68K |
Q2 2022 | share | Decrease | -5.65% | -462 shares | -4K | $77 | 7.70K |
Q1 2022 | share | Decrease | -6.60% | -577 shares | 52K | $73.03 | 8.17K |
Q4 2021 | share | Increase | +29.47% | 1.99K shares | 145K | $62.52 | 8.74K |
Q3 2021 | share | Increase | +4.08% | 265 shares | -34K | $59.17 | 6.75K |
Q2 2021 | share | Increase | +10.96% | 641 shares | 65K | $65.79 | 6.49K |
Q1 2021 | share | Increase | +5.29% | 294 shares | 25K | $62.15 | 5.85K |
Q4 2020 | share | Increase | +7.97% | 410 shares | 38K | $60.6 | 5.55K |
Q3 2020 | share | Increase | 0.00% | 5.14K shares | 306K | $58 | 5.14K |